Drug:
Reaction: MYELOSUPPRESSION
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26921459 |
CN |
74 | 2 |
Myelosuppression, Platelet count decreased, Neutrophil count decreased, Haemoglobin decreased, White blood cell count decreased, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, |
||||
| 102 | 26921662 |
CN |
54 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 103 | 26921805 |
CN |
5 | 2 |
Myelosuppression, Pyrexia, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Agranulocytosis, |
||||
DACTINOMYCIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 104 | 26921998 |
CN |
58 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
| 105 | 26922034 |
CN |
38 | 2 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 106 | 26922040 |
CN |
47 | 2 |
Haemorrhage intracranial, Bone marrow failure, Pancytopenia, Myelosuppression, Fatigue, Off label use, |
||||
OLAPARIB, OLAPARIB, TEMOZOLOMIDE, ATEZOLIZUMAB, |
||||
| 107 | 26922061 |
CN |
69 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 108 | 26922113 |
CN |
74 | 1 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 109 | 26922118 |
CN |
65 | 2 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 110 | 26922316 |
CN |
42 | 2 |
Myelosuppression, Pyrexia, Asthenia, Arthralgia, |
||||
PERTUZUMAB, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 111 | 26922533 |
CN |
||
Myelosuppression, Blood glucose increased, Pneumonia, Herpes zoster, Hepatic function abnormal, Off label use, |
||||
RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, METHYLPREDNISOLONE, |
||||
| 112 | 26923076 |
CN |
52 | 1 |
Myelosuppression, Malignant neoplasm progression, Septic shock, Febrile neutropenia, Escherichia infection, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 113 | 26923121 |
US |
2 | |
Myelosuppression, Febrile neutropenia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHIMAZOLE, |
||||
| 114 | 26923247 |
CN |
50 | 2 |
Myelosuppression, Polyp, Alanine aminotransferase abnormal, Palmar-plantar erythrodysaesthesia syndrome, Skin fissures, Gastric polyps, Chronic gastritis, Aspartate aminotransferase abnormal, Myelosuppression, Mouth ulceration, Lip ulceration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 115 | 26923580 |
CN |
42 | 2 |
Myelosuppression, Product use issue, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 116 | 26923720 |
JP |
76 | 1 |
Acute myeloid leukaemia recurrent, Myelosuppression, Rash, |
||||
(DAUNORUBICIN AND CYTARABINE) LIPOSOME, |
||||
| 117 | 26923865 |
US |
52 | 2 |
Drug ineffective, Neurotoxicity, Myelosuppression, Neutropenia, |
||||
DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 118 | 26924368 |
CN |
33 | 2 |
Myelosuppression, Pyrexia, Nausea, Oropharyngeal discomfort, Mouth ulceration, Dysphagia, Hyperpyrexia, Suspected off label use, |
||||
METHOTREXATE SODIUM, |
||||
| 119 | 26924393 |
CN |
52 | 2 |
Myelosuppression, Drug ineffective, |
||||
LINEZOLID, MEROPENEM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, METHYLPREDNISOLONE, MANNITOL, |
||||
| 120 | 26924482 |
CN |
56 | 2 |
Myelosuppression, Neutrophil count decreased, White blood cell count decreased, |
||||
TRASTUZUMAB, TRASTUZUMAB, PERTUZUMAB, PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 121 | 26924526 |
CN |
14 | 1 |
Myelosuppression, Gastrointestinal disorder, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 122 | 26924641 |
JP |
9 | 1 |
Myelosuppression, Off label use, |
||||
GILTERITINIB, GILTERITINIB, ITRACONAZOLE, |
||||
| 123 | 26925035 |
CN |
48 | 1 |
Myelosuppression, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 124 | 26925332 |
47 | 2 | |
Myelosuppression, |
||||
VINORELBINE, |
||||
| 125 | 26925617 |
59 | ||
Drug reaction with eosinophilia and systemic symptoms, Tubulointerstitial nephritis, Blood lactate dehydrogenase increased, Eosinophilia, Autoimmune haemolytic anaemia, Haemolysis, Myelosuppression, Bone marrow failure, Haemoglobin decreased, Platelet count decreased, Normochromic anaemia, |
||||
LINEZOLID, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 126 | 26926250 |
CN |
65 | 2 |
Myelosuppression, |
||||
| 127 | 26926399 |
CN |
58 | 2 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 128 | 26926506 |
CN |
64 | 1 |
Myelosuppression, |
||||
VENETOCLAX, CYTARABINE, AZACITIDINE, AZACITIDINE FOR, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 129 | 26926532 |
CN |
56 | 1 |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, |
||||
| 130 | 26926553 |
CN |
60 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, |
||||
| 131 | 26926580 |
CN |
69 | 2 |
Myelosuppression, |
||||
CARFILZOMIB, |
||||
| 132 | 26928711 |
50 | 2 | |
Sepsis, Cellulitis, Thrombocytopenia, Neutropenia, Myelosuppression, Diarrhoea, Mental status changes, |
||||
NELARABINE, |
||||
| 133 | 26914801 |
CN |
58 | 1 |
Myelosuppression, |
||||
CAPECITABINE, CAPECITABINE, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 134 | 26914847 |
CN |
60 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 135 | 26914916 |
CN |
71 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, BEVACIZUMAB, |
||||
| 136 | 26914926 |
CN |
49 | 1 |
Myelosuppression, Diarrhoea, Pyrexia, |
||||
CISPLATIN, CISPLATIN, |
||||
| 137 | 26914941 |
CN |
74 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 138 | 26914944 |
CN |
73 | 1 |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, |
||||
| 139 | 26914955 |
CN |
57 | 1 |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 140 | 26915103 |
CN |
71 | 2 |
Myelosuppression, |
||||
| 141 | 26915116 |
CN |
||
Myelosuppression, |
||||
OSIMERTINIB, |
||||
| 142 | 26915183 |
CN |
82 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 143 | 26915201 |
CN |
74 | 1 |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 144 | 26915394 |
CN |
61 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, |
||||
| 145 | 26915397 |
CN |
64 | 1 |
Myelosuppression, Haemoptysis, Diarrhoea, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 146 | 26915431 |
CN |
66 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 147 | 26915480 |
EU |
74 | 1 |
Myelosuppression, Agranulocytosis, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, LANSOPRAZOLE, |
||||
| 148 | 26915562 |
CN |
58 | 1 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 149 | 26915639 |
CN |
59 | 1 |
Differentiation syndrome, Myelosuppression, |
||||
TRETINOIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 150 | 26915657 |
CN |
53 | |
Hypoaesthesia, Nausea, Vomiting, Hypoaesthesia oral, Rash macular, Pruritus, Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 151 | 26916085 |
JP |
57 | 2 |
General physical health deterioration, Myelosuppression, Hyperadrenocorticism, Toxic shock syndrome streptococcal, |
||||
OSILODROSTAT, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CAPECITABINE, TRIMETHOPRIM, |
||||
| 152 | 26916260 |
CN |
72 | 1 |
Myelosuppression, Diarrhoea, Off label use, |
||||
GEFITINIB, PEMETREXED DISODIUM, CISPLATIN, BEVACIZUMAB, |
||||
| 153 | 26916274 |
CN |
61 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 154 | 26916480 |
CN |
60 | 1 |
Myelosuppression, Haemoptysis, Rash, Pruritus, Respiratory failure, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, |
||||
| 155 | 26916623 |
CN |
25 | 2 |
Myelosuppression, Off label use, |
||||
FRUQUINTINIB, FRUQUINTINIB, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 156 | 26916665 |
CN |
37 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, PERTUZUMAB, |
||||
| 157 | 26916683 |
CN |
35 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, |
||||
| 158 | 26916742 |
RU |
||
Myelosuppression, Febrile neutropenia, Pancytopenia, Respiratory failure, Alpha haemolytic streptococcal infection, Sepsis, Pseudomonas infection, |
||||
FLUDARABINE PHOSPHATE, CYTARABINE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, |
||||
| 159 | 26916792 |
CN |
60 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 160 | 26917112 |
US |
72 | 1 |
Myelosuppression, Haematuria, Ecchymosis, Escherichia infection, Shock, Mouth haemorrhage, Dengue fever, Pancytopenia, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 161 | 26917351 |
CN |
50 | |
Myelosuppression, White blood cell count decreased, Platelet count decreased, |
||||
RUXOLITINIB, |
||||
| 162 | 26917713 |
CN |
36 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 163 | 26917877 |
CN |
55 | 2 |
Myelosuppression, Inappropriate schedule of product administration, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 164 | 26918034 |
CN |
70 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, |
||||
| 165 | 26918404 |
EU |
68 | 2 |
Myelosuppression, Neutropenia, |
||||
OLAPARIB, |
||||
| 166 | 26918712 |
CN |
45 | 2 |
Myelosuppression, Hepatic function abnormal, |
||||
EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 167 | 26918805 |
CN |
18 | 1 |
Myelosuppression, Condition aggravated, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Pyrexia, Asthenia, |
||||
CYTARABINE, FLUDARABINE PHOSPHATE, |
||||
| 168 | 26918908 |
CN |
53 | 2 |
Myelosuppression, Abdominal distension, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, |
||||
| 169 | 26919020 |
54 | 2 | |
Myelosuppression, |
||||
CETUXIMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, |
||||
| 170 | 26919168 |
43 | 2 | |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 171 | 26919450 |
50 | 2 | |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
| 172 | 26909837 |
CN |
71 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Mean cell volume increased, Red cell distribution width increased, Platelet count decreased, Plateletcrit decreased, |
||||
RIBOCICLIB, |
||||
| 173 | 26909955 |
CN |
64 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 174 | 26909992 |
CN |
49 | |
Myelosuppression, |
||||
GOSERELIN, GOSERELIN, |
||||
| 175 | 26910016 |
CN |
70 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, |
||||
| 176 | 26910051 |
CN |
61 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 177 | 26910062 |
CN |
37 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 178 | 26910126 |
CN |
33 | 2 |
White blood cell count decreased, Platelet count decreased, Neutrophil count decreased, Haemoglobin decreased, Myelosuppression, |
||||
VENETOCLAX, CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 179 | 26910398 |
CN |
60 | 1 |
Myelosuppression, |
||||
OBINUTUZUMAB, |
||||
| 180 | 26910469 |
CN |
36 | |
Myelosuppression, |
||||
GOSERELIN, GOSERELIN, LETROZOLE, LETROZOLE TABLETS, ABEMACICLIB, |
||||
| 181 | 26910587 |
JP |
9 | 2 |
Myelosuppression, Haematuria, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 182 | 26910861 |
CN |
47 | 2 |
Myelosuppression, |
||||
VENETOCLAX, CYTARABINE, CLADRIBINE, |
||||
| 183 | 26911002 |
52 | 2 | |
Drug ineffective, Neurotoxicity, Myelosuppression, Neutropenia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MERCAPTOPURINE, CARBOPLATIN, TRASTUZUMAB, |
||||
| 184 | 26911390 |
CN |
58 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, PERTUZUMAB, CARBOPLATIN, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, TRASTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 185 | 26911601 |
CN |
36 | 1 |
Hyperpyrexia, White blood cell count decreased, Myelosuppression, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, RITUXIMAB, EPIRUBICIN HYDROCHLORIDE, POLATUZUMAB VEDOTIN, |
||||
| 186 | 26911622 |
AE |
41 | 2 |
Gastrointestinal toxicity, Myelosuppression, Anal abscess, Neutropenia, Nausea, Diarrhoea, |
||||
PERTUZUMAB, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, TRASTUZUMAB, CARBOPLATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 187 | 26911651 |
CN |
48 | 1 |
Myelosuppression, Off label use, |
||||
BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 188 | 26911673 |
CN |
69 | 1 |
Hypokalaemia, Immune-mediated enterocolitis, Febrile neutropenia, Myelosuppression, Pneumonia, Upper gastrointestinal haemorrhage, Thrombosis, Hypocalcaemia, Hypochloraemia, Hyponatraemia, Anaemia, Hypoalbuminaemia, Hypomagnesaemia, Oral disorder, Pyrexia, Stomatitis, Platelet count decreased, White blood cell count decreased, Cough, Dizziness, Fatigue, |
||||
NIVOLUMAB, CISPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 189 | 26911807 |
JP |
60 | |
Colitis, Myelosuppression, Oedema, |
||||
DURVALUMAB, TREMELIMUMAB, |
||||
| 190 | 26912497 |
CN |
77 | 2 |
Myelosuppression, Vomiting, Nausea, Abdominal distension, |
||||
VENETOCLAX, |
||||
| 191 | 26912499 |
CN |
2 | |
Gastrooesophageal reflux disease, Nausea, Myelosuppression, |
||||
CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 192 | 26912774 |
CN |
51 | 1 |
Myelosuppression, Infection, Asthenia, Anaemia, Abdominal pain upper, Insomnia, Pyrexia, |
||||
CYTARABINE, IDARUBICIN HYDROCHLORIDE, |
||||
| 193 | 26912944 |
CN |
53 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, COVID-19, Pyrexia, |
||||
PALBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 194 | 26913285 |
CN |
74 | 2 |
Myelosuppression, |
||||
OLAPARIB, |
||||
| 195 | 26913740 |
CN |
70 | 1 |
Myelosuppression, |
||||
CETUXIMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 196 | 26913745 |
CN |
61 | 2 |
Myelosuppression, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, CAPECITABINE, |
||||
| 197 | 26913762 |
2 | ||
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 198 | 26913781 |
65 | 2 | |
Myelosuppression, |
||||
| 199 | 26913810 |
57 | 2 | |
Thrombocytosis, Thrombocytosis, Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, |
||||
| 200 | 26913936 |
70 | 2 | |
Malignant neoplasm progression, Jaundice cholestatic, Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30